<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03347474</url>
  </required_header>
  <id_info>
    <org_study_id>2018-10-25 DBS-NAc Meth</org_study_id>
    <nct_id>NCT03347474</nct_id>
  </id_info>
  <brief_title>Deep Brain Stimulation of Nucleus Accumbens for Methamphetamine Addiction</brief_title>
  <official_title>Deep Brain Stimulation of Nucleus Accumbens for Methamphetamine Addiction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ruijin Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to assess the efficacy of bilateral deep brain
      stimulation (DBS) of the Nucleus Accumbens(NAc) as a novel treatment in severe
      methamphetamine addiction. Our hypothesis is that bilateral DBS of the NAc will significantly
      reduce the craving for methamphetamine.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All subjects will receive bilateral surgical implantation of DBS system</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in 10-point visual analog scale of carving</measure>
    <time_frame>Baseline (preoperative),3 months,6 months, 12 months</time_frame>
    <description>The score of scale is from 0 to 10. 0 represents no carving for drug, 10 means the greatest degree of carving for drug.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in Obsessive Compulsive Drug Use Scale</measure>
    <time_frame>Baseline (preoperative),3 months,6 months, 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side Effect</measure>
    <time_frame>Baseline（preoperative）,3 months, 6 months, 12months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Hamilton Anxiety Scale</measure>
    <time_frame>Baseline（preoperative）,3 months, 6 months, 12months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Hamilton Depression Scale</measure>
    <time_frame>Baseline（preoperative）,3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Quality of Life Assessment (SF-36)</measure>
    <time_frame>Baseline（preoperative）,3 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in World Health Organization Quality of Life-BREF(WHO-BREF)</measure>
    <time_frame>Baseline（preoperative）,3 months,6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chang in Pittsburgh Sleep Quality Index</measure>
    <time_frame>Baseline（preoperative）,3 months,6 months, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropsychological measures(Scores of cognitive battery)</measure>
    <time_frame>Baseline（preoperative）,6 months,12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Fagerstrom Test of Nicotine Dependence(FTND)</measure>
    <time_frame>Baseline（preoperative）,3 months,6 months, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Treatment Methamphetamine Addiction</condition>
  <arm_group>
    <arm_group_label>Bilateral surgical implantation of DBS system to NAc</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral surgical implantation of DBS system to NAc</intervention_name>
    <description>The Medtronic, PINS and SceneRay DBS device will be utilized in the present study.</description>
    <arm_group_label>Bilateral surgical implantation of DBS system to NAc</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DSM-IV-TR diagnosis of Drug addiction disorder;

          -  Age 18-65 years old;

          -  Proficiency in Mandarin language;

          -  Failure to detox more than three times;

          -  Capacity to provide informed consent (understanding of the study purpose and methods);

        Exclusion Criteria:

          -  Multidrug abuse and formation of addiction;

          -  Serious and unstable organic diseases (e.g. unstable coronal heart disease);

          -  Any history of seizure disorder or hemorrhagic stroke;

          -  Past stereotactic neurosurgical intervention;

          -  Neurological disease (Abnormal PET-CT, MRI, EEG)

          -  Contraindications of MRI-examination, e.g. implanted cardiac pacemaker/ heart
             defibrillator;

          -  Contraindications of stereotactic intervention, e.g. increased bleeding disposition,
             cerebrovascular diseases (e.g. arteriovenous malfunction, aneurysms, systemic vascular
             diseases);

          -  HIV positive;

          -  Pregnancy and/or lactation;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chencheng Zhang, MD</last_name>
    <phone>+086-18217122884</phone>
    <email>i@cczhang.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Ruijin Hospital Functional Neurosurgery</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chencheng Zhang, MD</last_name>
      <phone>+086-18217122884</phone>
      <email>i@cczhang.org</email>
    </contact>
    <contact_backup>
      <last_name>Yingying Zhang, MSc</last_name>
      <phone>+086-17602137369</phone>
      <email>zhyy019@126.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Kuhn J, Möller M, Treppmann JF, Bartsch C, Lenartz D, Gruendler TO, Maarouf M, Brosig A, Barnikol UB, Klosterkötter J, Sturm V. Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction. Mol Psychiatry. 2014 Feb;19(2):145-6. doi: 10.1038/mp.2012.196. Epub 2013 Jan 22.</citation>
    <PMID>23337942</PMID>
  </reference>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>September 3, 2017</study_first_submitted>
  <study_first_submitted_qc>November 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2017</study_first_posted>
  <last_update_submitted>October 24, 2018</last_update_submitted>
  <last_update_submitted_qc>October 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruijin Hospital</investigator_affiliation>
    <investigator_full_name>Bomin Sun</investigator_full_name>
    <investigator_title>Director of the Department of Functional Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>Bilateral Nucleus Accumbens</keyword>
  <keyword>Methamphetamine Addiction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Behavior, Addictive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

